Clostridioides Difficile Infection Clinical Trials

15 recruiting

Frequently Asked Questions

Common questions about Clostridioides Difficile Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting
Phase 3

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Clostridium Difficile Infection RecurrenceClostridium DifficileClostridioides Difficile Infection+7 more
Vedanta Biosciences, Inc.852 enrolled214 locationsNCT06237452
Recruiting

Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation

Clostridioides Difficile Infection Recurrence
Fondazione Policlinico Universitario Agostino Gemelli IRCCS20 enrolled1 locationNCT05739825
Recruiting
Phase 2

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Clostridioides Difficile Infection
AstraZeneca230 enrolled111 locationsNCT07285213
Recruiting
Phase 1Phase 2

Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients

Clostridioides Difficile InfectionRecurrent Infection
Hospices Civils de Lyon56 enrolled9 locationsNCT06306014
Recruiting
Phase 2Phase 3

LMN-201 for Prevention of C. Difficile Infection Recurrence

Clostridioides Difficile Infection
Lumen Bioscience, Inc.375 enrolled16 locationsNCT05330182
Recruiting

Clostridioides Difficile: Understanding Responses and Treatment Effects

Clostridioides Difficile Infection
Umeå University200 enrolled1 locationNCT07374094
Recruiting

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Clostridioides Difficile Infection Recurrence
Bactolife A/S60 enrolled1 locationNCT07250724
Recruiting
Phase 2Phase 3

Secondary Prevention of Clostridioides Difficile Using Vancomycin

Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
McGill University Health Centre/Research Institute of the McGill University Health Centre300 enrolled1 locationNCT06979609
Recruiting
Phase 3

Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence

Clostridioides Difficile Infection
Benoit Guery220 enrolled7 locationsNCT05266807
Recruiting
Not Applicable

FMT in Initial CDI

Clostridioides Difficile Infection
Turku University Hospital140 enrolled1 locationNCT05257538
Recruiting
Not Applicable

Evaluation of GeoHAI Implementation

Clostridioides Difficile Infection
Ohio State University25 enrolled1 locationNCT05612672
Recruiting
Not Applicable

Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain in Nephrology and Transplantation Department

Clostridioides Difficile Infection
Medical University of Silesia300 enrolled1 locationNCT06859437
Recruiting

Study of Clostridioides Difficile in Infants

Clostridioides Difficile Infection
Westlake University300 enrolled1 locationNCT06788769
Recruiting
Phase 2

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

Clostridium Difficile InfectionClostridioides Difficile InfectionClostridium Difficile Diarrhea+1 more
University of Virginia260 enrolled2 locationsNCT04305769
Recruiting
Not Applicable

Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection

Clostridioides Difficile Infection
Rambam Health Care Campus196 enrolled6 locationsNCT05709184
Recruiting

Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections

Clostridioides Difficile InfectionIntestinal Infection
The Second Hospital of Nanjing Medical University100 enrolled1 locationNCT03895593
Recruiting
Phase 3

Gut Bugs for C. Difficile Infection

Recurrent Clostridioides difficile infectionFirst episode Clostridioides difficile infectionRefractory Clostridioides difficile infection
University of Auckland84 enrolled1 locationACTRN12624000133538
Recruiting

Washed Microbiota Transplantation for Clostridioides Difficile Infection

Clostridioides Difficile Infection
The Second Hospital of Nanjing Medical University100 enrolled1 locationNCT06106698